One thing nice about being an investor in the small biotech space is that there is never a dull momentBesides being one of the highest-beta parts of the market, there is always a trial milestone or Food and Drug Administration (FDA) action on the horizonSo, let's look at potential catalysts coming up quickly for three small biotech stocks I have p...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.